DFS was significantly better for patients who underwent allogeneic bone marrow transplantation as first line treatment for leukemic transformation than for those, including the nine patients who ...

Outcome after bone marrow transplant (BMT ... and acute and chronic graft-versus-host disease (GVHD). Bronchiolitis obliterans organizing pneumonia (BOOP) is a respiratory disorder characterized ...

Korean regenerative medicine company CGBio, affiliated with Daewoong Pharmaceutical, announced Monday the establishment of Sol Cent Bio Co. Ltd., a joint ventur ...

Selecting the right tissue bank is essential for ensuring the safety and effectiveness of allograft implants. Learn how to ...

Mesoblast shares jumped after the biotechnology group reported "continued momentum" with the US Food and Drug Administration ...

Zemcelpro provides an option for people with a hematologic malignancy who need a blood stem cell transplant but have no ...

The global Orthobiologics Market is projected to be valued at USD 5,762.7 million in 2025, reaching USD 8,287.3 million by 2035, with a compound annual growth rate (CAGR) of 3.7% during the forecast ...

A meta-analysis suggests allogeneic stem cell transplantation (allo-SCT) should not be recommended following first-line ...

All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and ...